A Different R&D Path
Game-Changing Ideas & 革新
Given this shift in innovation origination, we have sought to follow a different R&D path than other companies.
We embrace a model that defines our position in this new ecosystem – as a magnet for game-changing ideas and innovation. A large percentage of our pipeline is sourced by partnering with biotech companies, academia and other pharmaceutical companies globally. Through this approach, we drive strong R&D productivity by delivering innovative therapies that create long-term shared value for Allergan, for customers and for patients.
Our R&D model has helped to build leadership in several therapeutic areas and drive the Company's long-term growth. Today, Allergan is rich with programs in development across four core therapeutic areas, with key candidates for global development in 医学美学 and Dermatology, 眼睛护理, 中枢神经系统 disorders and 肠胃病.
Through this R&D strategy, we have added product opportunities from the innovation ecosystem across our key therapeutic areas. All programs enter our best-in-class product development and commercialization organization to build a sustainable portfolio that addresses unmet needs and aligns with our key therapeutic areas.
We are committed to this strategy, and to continuing to invest significant dollars in R&D annually.